1. Home
  2. TAYD vs TTRX Comparison

TAYD vs TTRX Comparison

Compare TAYD & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$55.76

Market Cap

170.7M

Sector

Industrials

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$7.69

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
TTRX
Founded
1955
2015
Country
United States
United States
Employees
N/A
2
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.7M
281.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TAYD
TTRX
Price
$55.76
$7.69
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$70.00
$8.00
AVG Volume (30 Days)
32.0K
125.6K
Earning Date
03-31-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
11.24
N/A
EPS
2.87
N/A
Revenue
$46,292,725.00
N/A
Revenue This Year
$0.25
N/A
Revenue Next Year
$19.78
N/A
P/E Ratio
$19.32
N/A
Revenue Growth
3.84
N/A
52 Week Low
$40.50
$2.57
52 Week High
$90.37
$11.69

Technical Indicators

Market Signals
Indicator
TAYD
TTRX
Relative Strength Index (RSI) 49.93 46.44
Support Level $53.46 $4.40
Resistance Level $59.13 $10.48
Average True Range (ATR) 2.27 0.89
MACD -0.17 -0.30
Stochastic Oscillator 49.95 3.62

Price Performance

Historical Comparison
TAYD
TTRX

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: